AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1021226 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (Tam)
Number of subjects: 0
Study 1021226 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (Tam) plus fluoxymesterone (Flu)
Number of subjects: 0
Study 31451361 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education tailored to health literacy
Number of subjects: 118
Study 31451361 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 118
Study 31533660 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPEC group (Curative Resection + intraoperative HIPEC with cisplatin 50 mg/m2 at 42.0 ± 1.0 °C for 60 min)
Number of subjects: 80
Study 31533660 — intervention group
Group type: COMPARATOR
Intervention: Control group (Curative Resection only)
Number of subjects: 80
Study 28988646 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg intravenous every 3 weeks
Number of subjects: 86
Study 25742161 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Chinese eye exercises group
Number of subjects: 190
Study 25742161 — intervention group
Group type: COMPARATOR
Intervention: Sham point eye exercises group
Number of subjects: 190
Study 25742161 — intervention group
Group type: COMPARATOR
Intervention: Eyes closed group
Number of subjects: 190
Study 23505208 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir
Number of subjects: 0
Study 23505208 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine
Number of subjects: 0
Study 16461865 — intervention group
Group type: EXPERIMENTAL
Intervention: 192 mg of depot naltrexone
Number of subjects: 60
Study 16461865 — intervention group
Group type: EXPERIMENTAL
Intervention: 384 mg of depot naltrexone
Number of subjects: 60
Study 16461865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 15243283 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17beta-estradiol 50 microg daily plus nomegestrole acetate 5 mg/day for 12 days per 28-day cycle for 6 months (Group A)
Number of subjects: 20
Study 15243283 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal 17beta-estradiol 300 microg/day plus nomegestrole acetate 5 mg/day for 12 days per 28-day cycle for 6 months (Group B)
Number of subjects: 20
Study 10916105 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate-free hemodiafiltration with monitoring of blood volume and automatic biofeedback
Number of subjects: 12
Study 10916105 — intervention group
Group type: COMPARATOR
Intervention: Acetate-free hemodiafiltration with standard ultrafiltration control
Number of subjects: 12
Study 8848321 — intervention group
Group type: EXPERIMENTAL
Intervention: External sphincterotomy combined with bladder neck resection
Number of subjects: 125
Study 8848321 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder neck resection alone
Number of subjects: 125
Study 1383902 — intervention group
Group type: EXPERIMENTAL
Intervention: COPP
Number of subjects: 45
Study 1383902 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 45
Study 3863444 — intervention group
Group type: EXPERIMENTAL
Intervention: Bite plate with a frontal plateau
Number of subjects: 20
Study 3863444 — intervention group
Group type: EXPERIMENTAL
Intervention: Full‐coverage stabilization splint
Number of subjects: 20
Study 31832674 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 0
Study 31832674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31480482 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention
Number of subjects: 1211
Study 31480482 — intervention group
Group type: EXPERIMENTAL
Intervention: Top-down intervention (TDI)
Number of subjects: 1211
Study 31480482 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1211
Study 28067613 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified independent cue test
Number of subjects: 6
Study 28067613 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditions promoting output interference
Number of subjects: 6
Study 28067613 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditions controlling output interference
Number of subjects: 6
Study 26107752 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting injectable risperidone
Number of subjects: 86
Study 26107752 — intervention group
Group type: COMPARATOR
Intervention: Oral risperidone
Number of subjects: 86
Study 26107752 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting risperidone
Number of subjects: 86
Study 26107752 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication adherence
Number of subjects: 86
Study 23880183 — intervention group
Group type: EXPERIMENTAL
Intervention: ezFMD
Number of subjects: 306
Study 21699740 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Care Program (CCP)
Number of subjects: 32
Study 21699740 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 32
Study 20368220 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg, daily)
Number of subjects: 23
Study 20368220 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 diabetic patients with atherosclerosis and 14 diabetic patients without atherosclerosis, no statin therapy)
Number of subjects: 23
Study 17366757 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene education
Number of subjects: 61
Study 17366757 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand and nail cleaning education
Number of subjects: 61
Study 17366757 — intervention group
Group type: COMPARATOR
Intervention: Overall education (both groups)
Number of subjects: 61
Study 15087990 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pulse frequency stimulus (n = 19)
Number of subjects: 40
Study 15087990 — intervention group
Group type: COMPARATOR
Intervention: High pulse frequency stimulus (n = 21)
Number of subjects: 40
Study 11473862 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.2 mg
Number of subjects: 18
Study 11473862 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.4 mg
Number of subjects: 18
Study 11473862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9736788 — intervention group
Group type: EXPERIMENTAL
Intervention: Long slow hemodialysis (8 hours, 3 times a week, using 1-1.8 m² cellulosic dialyzers, blood flow 220 ml/min, dialysate flow 500 ml/min, acetate or bicarbonate buffer)
Number of subjects: 18
Study 9736788 — intervention group
Group type: EXPERIMENTAL
Intervention: n-PDUR
Number of subjects: 18
Study 9736788 — intervention group
Group type: EXPERIMENTAL
Intervention: Long slow hemodialysis
Number of subjects: 18
Study 7988349 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) 1.2 micrograms/kg/day intravenously for four weeks
Number of subjects: 38
Study 7988349 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methyl vitamin B12 (VB12) 1500 micrograms/day for four weeks
Number of subjects: 38
Study 7988349 — intervention group
Group type: COMPARATOR
Intervention: No drugs (control group A)
Number of subjects: 38
Study 2499223 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 30
Study 2499223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2499223 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 30
Study 31931686 — intervention group
Group type: EXPERIMENTAL
Intervention: PS‐cCBT
Number of subjects: 330
Study 31931686 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 330
Study 30908880 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaft of the radius (diaphysis)
Number of subjects: 3
Study 30908880 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal metaphysis
Number of subjects: 3
Study 30908880 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal metaphysis
Number of subjects: 3
Study 30908880 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphysis
Number of subjects: 3
Study 28580894 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA guidelines implemented in adult teaching facilities (2007-2009)
Number of subjects: 0
Study 28580894 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA guidelines and interventions (2010-2015)
Number of subjects: 0
Study 28580894 — intervention group
Group type: COMPARATOR
Intervention: CLABSI incidence (2006-2007)
Number of subjects: 0
Study 28580894 — intervention group
Group type: COMPARATOR
Intervention: CLABSI incidence (2010-2015)
Number of subjects: 0
Study 26305004 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient history and clinical examination
Number of subjects: 180
Study 26305004 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient history, clinical examination, and MRI findings
Number of subjects: 180
Study 22643242 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein condition (PROT)
Number of subjects: 30
Study 22643242 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate condition (CARB)
Number of subjects: 30
Study 22643242 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 30
Study 21729308 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hypotonic solution (0.23% or 0.40% sodium chloride in glucose)
Number of subjects: 0
Study 21729308 — intervention group
Group type: COMPARATOR
Intervention: Intravenous near-isotonic solution (0.81% sodium chloride in glucose)
Number of subjects: 0
Study 21729308 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (hypotonic and near-isotonic)
Number of subjects: 0
Study 19467416 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified UPPP
Number of subjects: 32
Study 19467416 — intervention group
Group type: COMPARATOR
Intervention: Classic UPPP
Number of subjects: 32
Study 19467416 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 16132994 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification and IOL implantation in eyes with angle-closure glaucoma
Number of subjects: 24
Study 16132994 — intervention group
Group type: COMPARATOR
Intervention: Partner eyes with narrow angle and iridectomy or iridotomy
Number of subjects: 24
Study 15283928 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (3 times a week for 12 weeks) with HRT
Number of subjects: 32
Study 15283928 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (3 times a week for 12 weeks) with NHRT
Number of subjects: 32
Study 15283928 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (3 times a week for 12 weeks)
Number of subjects: 32
Study 15283928 — intervention group
Group type: COMPARATOR
Intervention: Control group (no resistance training) with HRT
Number of subjects: 32
Study 15283928 — intervention group
Group type: COMPARATOR
Intervention: Control group (no resistance training) with NHRT
Number of subjects: 32
Study 11196741 — intervention group
Group type: EXPERIMENTAL
Intervention: New measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham)
Number of subjects: 44
Study 11196741 — intervention group
Group type: COMPARATOR
Intervention: Commercially available MMR vaccine (MMR-II, Merck)
Number of subjects: 44
Study 9031821 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine
Number of subjects: 28
Study 9031821 — intervention group
Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 28
Study 7687948 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational and family support services and pediatric follow‐up
Number of subjects: 985
Study 7687948 — intervention group
Group type: COMPARATOR
Intervention: Follow-up group (control)
Number of subjects: 985
Study 2872514 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 150
Study 2872514 — intervention group
Group type: COMPARATOR
Intervention: Tonsillectomy
Number of subjects: 150
Study 2872514 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 150
Study 30566712 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative PFC injection
Number of subjects: 30
Study 30566712 — intervention group
Group type: COMPARATOR
Intervention: No PFC injection (Control)
Number of subjects: 30
Study 30566712 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with metamorphopsia
Number of subjects: 30
Study 30566712 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative macula-off RRD
Number of subjects: 30
Study 27491822 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of the blood level of the biomarker soluble urokinase plasminogen activator receptor (suPAR) within 2 hours after admission, with immediate reporting to treating physicians in the ED.
Number of subjects: 10000
Study 27491822 — intervention group
Group type: EXPERIMENTAL
Intervention: Education of all ED physicians in the prognostic capabilities of suPAR prior to the inclusion period.
Number of subjects: 10000
Study 27491822 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of prognostic information from suPAR.
Number of subjects: 10000
Study 24884415 — intervention group
Group type: EXPERIMENTAL
Intervention: Women indicating that they had been in labour for 24 hours or longer at the time of hospital admission
Number of subjects: 1247
Study 22258294 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized 45 min relaxation session with a health psychologist and relaxation exercise CDs
Number of subjects: 60
Study 22258294 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 20388042 — intervention group
Group type: EXPERIMENTAL
Intervention: eMOD web-based comprehensive information system
Number of subjects: 40
Study 20388042 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional education)
Number of subjects: 40
Study 18373577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored daily messages via cellphone prompting to enhance diabetic self-care behaviour
Number of subjects: 30
Study 18373577 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetes self-management
Number of subjects: 30
Study 16078923 — intervention group
Group type: EXPERIMENTAL
Intervention: Apheresis platelets treated with riboflavin (500 micromol per L) and UV light (6.2 J per mL)
Number of subjects: 24
Study 16078923 — intervention group
Group type: COMPARATOR
Intervention: Control apheresis platelets (untreated)
Number of subjects: 24
Study 16078923 — intervention group
Group type: EXPERIMENTAL
Intervention: Apheresis platelets treated with riboflavin and UV light
Number of subjects: 24
Study 12614536 — intervention group
Group type: EXPERIMENTAL
Intervention: Iscador Qu (IQ)
Number of subjects: 48
Study 12614536 — intervention group
Group type: EXPERIMENTAL
Intervention: Iscador Pini (IP)
Number of subjects: 48
Study 12614536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 10915328 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical grading systems (e.g., grades I, II, and III)
Number of subjects: 0
Study 10915328 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive typologic system
Number of subjects: 0
Study 8882824 — intervention group
Group type: EXPERIMENTAL
Intervention: Early recoronary angiography after 6 weeks with differentiated reintervention
Number of subjects: 324
Study 8882824 — intervention group
Group type: EXPERIMENTAL
Intervention: Second reintervention after 1/4 year
Number of subjects: 324
Study 8882824 — intervention group
Group type: EXPERIMENTAL
Intervention: Type-I dissection
Number of subjects: 324
Study 8882824 — intervention group
Group type: EXPERIMENTAL
Intervention: Type-II dissection
Number of subjects: 324
Study 8882824 — intervention group
Group type: EXPERIMENTAL
Intervention: Type-IV dissection
Number of subjects: 324
Study 8882824 — intervention group
Group type: EXPERIMENTAL
Intervention: Type-III dissection
Number of subjects: 324
Study 1857138 — intervention group
Group type: EXPERIMENTAL
Intervention: Firm system intervention with private physician groups randomized to four geographic medical wards (oncology, cardiology, nephrology, diabetes)
Number of subjects: 350
Study 1857138 — intervention group
Group type: EXPERIMENTAL
Intervention: Problems related to the firm system intervention
Number of subjects: 350
Study 6956376 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal (i.t.) chemoprophylaxis
Number of subjects: 408
Study 6956376 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal (i.t.) chemoprophylaxis during consolidation
Number of subjects: 408
Study 6956376 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS chemoprophylaxis during consolidation
Number of subjects: 408
Study 6956376 — intervention group
Group type: COMPARATOR
Intervention: Cranial radiotherapy plus i.t. MTX
Number of subjects: 408
Study 31072714 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed loop group (EndoButton)
Number of subjects: 79
Study 31072714 — intervention group
Group type: COMPARATOR
Intervention: Adjustable loop group (TightRope)
Number of subjects: 79
Study 28453896 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical cystectomy (RC)
Number of subjects: 45
Study 28453896 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective bladder preservation (SBP)
Number of subjects: 45
Study 26964157 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 66
Study 26964157 — intervention group
Group type: COMPARATOR
Intervention: Western medication (cetirizine hydrochloride)
Number of subjects: 66
Study 23321375 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst stimulation
Number of subjects: 15
Study 23321375 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic stimulation
Number of subjects: 15
Study 23321375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 21300334 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist administered from day 2 of the menstrual cycle for 3 consecutive days, followed by standard treatment with daily injections of recombinant FSH (rFSH) starting on day 2 of the cycle at a dose of 150-225 IU/day, and GnRH antagonists from cycle day 7 onward.
Number of subjects: 69
Study 21300334 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with daily injections of recombinant FSH (rFSH) starting on day 2 of the cycle at a dose of 150-225 IU/day, and GnRH antagonists from cycle day 7 onward.
Number of subjects: 69
Study 19447196 — intervention group
Group type: EXPERIMENTAL
Intervention: 5Fr stent
Number of subjects: 249
Study 19447196 — intervention group
Group type: COMPARATOR
Intervention: 3Fr stent
Number of subjects: 249
Study 16549466 — intervention group
Group type: EXPERIMENTAL
Intervention: Free plant sterols
Number of subjects: 30
Study 16549466 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols esterified to fatty acids from sunflower oil
Number of subjects: 30
Study 16549466 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols esterified to very long‐chained fatty acids from fish oil
Number of subjects: 30
Study 16549466 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols combined with very long‐chained fatty acids from fish oil
Number of subjects: 30
Study 16549466 — intervention group
Group type: COMPARATOR
Intervention: Margarine (control)
Number of subjects: 30
Study 15457755 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobosiewicz method
Number of subjects: 58
Study 15457755 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 10191173 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.0-T scanner
Number of subjects: 6
Study 10191173 — intervention group
Group type: COMPARATOR
Intervention: 1.5-T scanner
Number of subjects: 6
Study 7804974 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO), total protein equals 2 mg/ml, administered once a week for 13 weeks and then once every 2 weeks for an additional 39 weeks
Number of subjects: 250
Study 7804974 — intervention group
Group type: COMPARATOR
Intervention: Placebo of live vaccinia vaccine virus (V), 10(5.4) TCID50/ml, administered once a week for 13 weeks and then once every 2 weeks for an additional 39 weeks
Number of subjects: 250
Study 7804974 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO)
Number of subjects: 250
Study 7804974 — intervention group
Group type: COMPARATOR
Intervention: Placebo of live vaccinia vaccine virus (V)
Number of subjects: 250
Study 7804974 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO) in male patients (n = 63)
Number of subjects: 250
Study 7804974 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO) in male patients aged 44-57 with 1-5 positive lymph nodes (n = 20)
Number of subjects: 250
Study 2129437 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEpo)
Number of subjects: 13
Study 339084 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 9
Study 339084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 7067069 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyposensitization with rye grass extract
Number of subjects: 36
Study 7067069 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36
Study 7067069 — intervention group
Group type: EXPERIMENTAL
Intervention: Children highly sensitized to rye allergen
Number of subjects: 36
Study 7067069 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-grass pollen season
Number of subjects: 36
Study 30561729 — intervention group
Group type: EXPERIMENTAL
Intervention: High hemoglobin group (12.5-13.5 g/dL)
Number of subjects: 127
Study 30561729 — intervention group
Group type: COMPARATOR
Intervention: Low hemoglobin group (10.5-11.5 g/dL)
Number of subjects: 127
Study 29504369 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with high dose Dermatophagoides farinae
Number of subjects: 40
Study 29504369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 26576716 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomic Regulation Therapy (ART) via vagus nerve stimulation (VNS)
Number of subjects: 60
Study 23985355 — intervention group
Group type: EXPERIMENTAL
Intervention: Group music therapy, no restrictions on frequency, duration, or contents.
Number of subjects: 113
Study 23985355 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 113
Study 23273285 — intervention group
Group type: EXPERIMENTAL
Intervention: Six standardized clinical tests focusing on movement control for back and hip
Number of subjects: 33